Nano-X Imaging received FDA 510(k) clearance for its multi-source Nanox.ARC scanner, disproving claims of fraud and sparking a rally in shares. Despite FDA approval, Nano-X's stock has fallen 53% ...
Nano-X is an under-the-radar medical device company that may very well transform healthcare for a billion people around the world. The stock went up 68% on May 1. Don't worry about the short-term ...
Nano-X Imaging Ltd. (NASDAQ:NNOX) Q3 2025 Earnings Call Transcript November 20, 2025 Nano-X Imaging Ltd. misses on earnings expectations. Reported EPS is $-0.65 EPS, expectations were $-0.22. Operator ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback